Stefania Gessi
Stefania Gessi
Verified email at unife.it
TitleCited byYear
A glance at adenosine receptors: novel target for antitumor therapy
S Merighi, P Mirandola, K Varani, S Gessi, E Leung, PG Baraldi, ...
Pharmacology & therapeutics 100 (1), 31-48, 2003
2292003
Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility
PG Baraldi, MA Tabrizi, S Gessi, PA Borea
Chemical reviews 108 (1), 238-263, 2008
2252008
The A3 adenosine receptor: an enigmatic player in cell biology
S Gessi, S Merighi, K Varani, E Leung, S Mac Lennan, PA Borea
Pharmacology & therapeutics 117 (1), 123-140, 2008
2072008
Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors
E Ongini, S Dionisotti, S Gessi, E Irenius, BB Fredholm
Naunyn-Schmiedeberg's archives of pharmacology 359 (1), 7-10, 1999
1851999
Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells
S Gessi, E Cattabriga, A Avitabile, G Lanza, L Cavazzini, N Bianchi, ...
Clinical Cancer Research 10 (17), 5895-5901, 2004
1712004
[3H] MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors
K Varani, S Merighi, S Gessi, KN Klotz, E Leung, PG Baraldi, B Cacciari, ...
Molecular Pharmacology 57 (5), 968-975, 2000
1642000
A2A adenosine receptors in human peripheral blood cells
S Gessi, K Varani, S Merighi, E Ongini, PA Borea
British journal of pharmacology 129 (1), 2-11, 2000
1632000
Adenosine receptors and cancer
S Gessi, S Merighi, V Sacchetto, C Simioni, PA Borea
Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (5), 1400-1412, 2011
1572011
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer …
S Merighi, A Benini, P Mirandola, S Gessi, K Varani, C Simioni, E Leung, ...
Molecular pharmacology 72 (2), 395-406, 2007
1552007
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells
S Merighi, P Mirandola, D Milani, K Varani, S Gessi, KN Klotz, E Leung, ...
Journal of Investigative Dermatology 119 (4), 923-933, 2002
1422002
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study
S Gessi, K Varani, S Merighi, E Cattabriga, V Iannotta, E Leung, ...
Molecular pharmacology 61 (2), 415-424, 2002
1382002
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils
K Varani, S Gessi, S Merighi, V Iannotta, E Cattabriga, S Spisani, ...
British journal of pharmacology 136 (1), 57-66, 2002
1362002
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells
S Merighi, A Benini, P Mirandola, S Gessi, K Varani, E Leung, ...
Biochemical pharmacology 72 (1), 19-31, 2006
1282006
Synthesis, biological activity, and molecular modeling investigation of new pyrazolo [4, 3-e]-1, 2, 4-triazolo [1, 5-c] pyrimidine derivatives as human A3 adenosine receptor …
PG Baraldi, B Cacciari, S Moro, G Spalluto, G Pastorin, T Da Ros, ...
Journal of medicinal chemistry 45 (4), 770-780, 2002
1282002
The A3 adenosine receptor: history and perspectives
PA Borea, K Varani, F Vincenzi, PG Baraldi, MA Tabrizi, S Merighi, ...
Pharmacological reviews 67 (1), 74-102, 2015
1252015
Adenosine as a multi-signalling guardian angel in human diseases: when, where and how does it exert its protective effects?
PA Borea, S Gessi, S Merighi, K Varani
Trends in pharmacological sciences 37 (6), 419-434, 2016
1232016
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 …
S Merighi, A Benini, P Mirandola, S Gessi, K Varani, E Leung, ...
Journal of Biological Chemistry 280 (20), 19516-19526, 2005
1212005
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists
PG Baraldi, MA Tabrizi, D Preti, A Bovero, R Romagnoli, F Fruttarolo, ...
Journal of medicinal chemistry 47 (6), 1434-1447, 2004
1212004
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line
S Merighi, K Varani, S Gessi, E Cattabriga, V Iannotta, C Ulouglu, ...
British journal of pharmacology 134 (6), 1215-1226, 2001
1212001
Pyrazolo [4, 3-e] 1, 2, 4-triazolo [1, 5-c] pyrimidine derivatives as highly potent and selective human A3 adenosine receptor antagonists: influence of the chain at the N8 …
PG Baraldi, B Cacciari, R Romagnoli, G Spalluto, S Moro, KN Klotz, ...
Journal of medicinal chemistry 43 (25), 4768-4780, 2000
1212000
The system can't perform the operation now. Try again later.
Articles 1–20